Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

New aminomethylcycline shows efficacy in pneumonia murine models

July 4, 2016

Arsanis MAbs target the LPS-O antigen of Klebsiella pneumoniae ST258

July 4, 2016

Phase I results for new generation fluoroquinolone lascufloxacin

July 4, 2016

Novel ARF6 inhibitors with robust in vivo efficacy

July 1, 2016

HXP-124 as a novel antifungal agent for the treatment for onychomycosis

July 1, 2016

SER-262 prevents recurrence in patients with primary CDI

June 30, 2016

ACRAF patents DNA gyrase and DNA topoisomerase IV inhibitors

June 30, 2016

Ablynx to license FOX technology for study of inhaled anti-RSV nanobody

June 29, 2016

Cempra submits solithromycin MAA to EMA

June 29, 2016

FDA approves Epclusa as pan-genotypic single-tablet regimen for chronic HCV infection

June 29, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...